GeneTether Therapeutics (XCNQ:GTTX) ROE % Adjusted to Book Value : -108.52% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is GeneTether Therapeutics ROE % Adjusted to Book Value?

GeneTether Therapeutics's ROE % for the quarter that ended in Dec. 2023 was -90.07%. GeneTether Therapeutics's PB Ratio for the quarter that ended in Dec. 2023 was 0.83. GeneTether Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -108.52%.

GeneTether Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for GeneTether Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneTether Therapeutics ROE % Adjusted to Book Value Chart

GeneTether Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

-89.10

-50.96

GeneTether Therapeutics Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial								-39.73	-42.78	-49.69	-8.52	-108.52

Competitive Comparison of GeneTether Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, GeneTether Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GeneTether Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GeneTether Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where GeneTether Therapeutics's ROE % Adjusted to Book Value falls into.

GeneTether Therapeutics ROE % Adjusted to Book Value Calculation

GeneTether Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-42.30%	/	0.83
	=	-50.96%

GeneTether Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-90.07%	/	0.83
	=	-108.52%

GeneTether Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of GeneTether Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

GeneTether Therapeutics (XCNQ:GTTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneTether Therapeutics Inc (XCNQ:GTTX) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

301-1665 Ellis Street, c/o Pushor Mitchell LLP, Kelowna, BC, CAN, V1Y 2B3

Website

https://www.genetether.com

GeneTether Therapeutics Inc is a genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. It is engaged in creating gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin.

GeneTether Therapeutics (XCNQ:GTTX) Headlines

No Headlines